Valerio Therapeutics

Research Valerio Therapeutics (ALVIO) on Bullrun: market cap EUR 106.13M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALVIO
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 106.13M
• Financial periodFY2025
• RevenueEUR 2.57M
• Revenue growth43.5%
• Net income-EUR 4.90M
• Free cash flowEUR 521.00K
• Gross margin67.1%

Valuation Snapshot

latest market cap is EUR 106.13M.

About Valerio Therapeutics

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody– drug conjugates, and chimeric antigen receptors.

Frequently asked questions

What is Valerio Therapeutics's market cap?

Valerio Therapeutics's market capitalization is EUR 106.13M.

What does Valerio Therapeutics do?

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.